- Humana publishes its own research, when it’s good for Humana. (Statnews)
- Why economists should listen to Scott Sumner.
- Why it’s hard to distinguish high-valued care from low-valued care in Medicare: patients are different. (Does this problem really cover 25% of Part B spending?)
- Among the almost 20 million people who have been disenrolled from Medicaid, nearly 1 in 4 report that they have not transitioned to other sources of coverage.
- The growth of national health care spending exceeds 6 percent and is projected to remain close to that level for a decade.
Category: Medicaid
The Real Reason Weight-Loss Drugs Have Fallen in Price
While the Trump Administration takes a victory lap celebrating its latest strong-arm negotiating, that does not tell the whole story. Drugmakers would rather not have Trump as an enemy, but no company gives away tens of billions of dollars annually if they do not have to. The reason drugmakers agreed to deep price concessions is due to growing competition in the GLP-1 weight-loss market.
Thursday Links
- Troubles at UnitedHealth.
- Urban hospitals at risk from Medicaid cuts. (NYT)
- Should pregnant women get to park in handicapped parking spaces? (WaPo)
- Comparing health outcomes across countries is fraught with errors.
- “Ghost networks” in Medicaid health plans: In many cases, most of the doctors either see no Medicaid patients or 10 or less. (WSJ)
Democrats Aghast at Trump Administration’s (Reasonable) Immigrant Health Restrictions
The following was reported in Kaiser Family Foundation Health News:
Foreigners seeking visas to live in the U.S. might be rejected if they have certain medical conditions, including diabetes or obesity, under a Thursday directive from the Trump administration.